Clearance of Rh D-positive red cells with monoclonal anti-D

Amanda Thomson(National Blood Transfusion Service), R. S. Lane(Bio Products Laboratory (United Kingdom)), P. Teesdale, M. Contreras, N. C. Hughes‐Jones, P.L. Mollison, Belinda M. Kumpel(NHS Blood and Transplant), G.E. Chapman(Bio Products Laboratory (United Kingdom)), B.D. Gorick

The Lancet

November 1, 1990

10.1016/0140-6736(90)92767-c

Cited by 68

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction

|Genomics|2005|114

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97